Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Deborah H Fuller

Showing results (1-10 of 62) with videos related to

Pageof 7
Sort By:
The New England Journal of Medicine|June 20, 2020
Amplifying RNA Vaccine DevelopmentDeborah H Fuller, Peter Berglund
AIDS Research and Human Retroviruses|February 17, 2022
<i>Letter to the Editor:</i> Prior Infection with Coccidioidomycosis in Nonhuman Primates and Impact on Simian Immunodeficiency Virus Disease and Vaccine ImmunogenicityDeborah H Fuller, Megan A O'Connor
Current Topics in Microbiology and Immunology|August 28, 2012
'Omics investigations of HIV and SIV pathogenesis and innate immunityRobert E Palermo, Deborah H Fuller
Methods (San Diego, Calif.)|September 26, 2006
Preclinical and clinical progress of particle-mediated DNA vaccines for infectious diseasesDeborah H Fuller, Peter Loudon, Connie Schmaljohn
Current Opinion in Molecular Therapeutics|November 19, 2002
Particle-mediated DNA vaccination of mice, monkeys and men: looking beyond the dogmaLendon G Payne, Deborah H Fuller, Joel R Haynes
Methods in Molecular Biology (Clifton, N.J.)|October 30, 2012
Optimizing particle-mediated epidermal delivery of an influenza DNA vaccine in ferretsEric J Yager, Cristy Stagnar, Ragisha Gopalakrishnan, et al.
Plos One|September 9, 2010
Oral immunization with a live coxsackievirus/HIV recombinant induces gag p24-specific T cell responsesRui Gu, Anae Shampang, Toufic Nashar, et al.
Plos One|October 27, 2021
B cell activating factor (BAFF) from neutrophils and dendritic cells is required for protective B cell responses against Salmonella typhimurium infectionRuna Kuley, Kevin E Draves, Deborah H Fuller, et al.
Transplantation Direct|July 19, 2016
Minor Antigen Vaccine-Sensitized DLI: In Vitro Responses Do Not Predict In Vivo EffectsSteven Lawrence Rosinski, Brad Stone, Scott S Graves, et al.
Vaccine|June 30, 2005
Clinical safety and efficacy of a powdered Hepatitis B nucleic acid vaccine delivered to the epidermis by a commercial prototype deviceLee K Roberts, Lori J Barr, Deborah H Fuller, et al.
Pageof 7

Showing results (1-10 of 62) with videos related to

Sort By:
Pageof 7
The New England Journal of Medicine|June 20, 2020
Amplifying RNA Vaccine DevelopmentDeborah H Fuller, Peter Berglund
AIDS Research and Human Retroviruses|February 17, 2022
<i>Letter to the Editor:</i> Prior Infection with Coccidioidomycosis in Nonhuman Primates and Impact on Simian Immunodeficiency Virus Disease and Vaccine ImmunogenicityDeborah H Fuller, Megan A O'Connor
Current Topics in Microbiology and Immunology|August 28, 2012
'Omics investigations of HIV and SIV pathogenesis and innate immunityRobert E Palermo, Deborah H Fuller
Methods (San Diego, Calif.)|September 26, 2006
Preclinical and clinical progress of particle-mediated DNA vaccines for infectious diseasesDeborah H Fuller, Peter Loudon, Connie Schmaljohn
Current Opinion in Molecular Therapeutics|November 19, 2002
Particle-mediated DNA vaccination of mice, monkeys and men: looking beyond the dogmaLendon G Payne, Deborah H Fuller, Joel R Haynes
Methods in Molecular Biology (Clifton, N.J.)|October 30, 2012
Optimizing particle-mediated epidermal delivery of an influenza DNA vaccine in ferretsEric J Yager, Cristy Stagnar, Ragisha Gopalakrishnan, et al.
Plos One|September 9, 2010
Oral immunization with a live coxsackievirus/HIV recombinant induces gag p24-specific T cell responsesRui Gu, Anae Shampang, Toufic Nashar, et al.
Plos One|October 27, 2021
B cell activating factor (BAFF) from neutrophils and dendritic cells is required for protective B cell responses against Salmonella typhimurium infectionRuna Kuley, Kevin E Draves, Deborah H Fuller, et al.
Transplantation Direct|July 19, 2016
Minor Antigen Vaccine-Sensitized DLI: In Vitro Responses Do Not Predict In Vivo EffectsSteven Lawrence Rosinski, Brad Stone, Scott S Graves, et al.
Vaccine|June 30, 2005
Clinical safety and efficacy of a powdered Hepatitis B nucleic acid vaccine delivered to the epidermis by a commercial prototype deviceLee K Roberts, Lori J Barr, Deborah H Fuller, et al.
Pageof 7